Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
Provided By GlobeNewswire
Last update: May 8, 2025
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) --
Read more at globenewswire.com
